Showing posts sorted by date for query VAPING. Sort by relevance Show all posts
Showing posts sorted by date for query VAPING. Sort by relevance Show all posts

Wednesday, October 28, 2026

 

3 out of 4 responses to UK smoke-free generation consultation were AI bot-generated



And overwhelmingly targeted at opposing restrictions on disposable vape sales; scale and consistency of responses suggest a coordinated campaign




BMJ Group






Three quarters of all the responses to the UK’s public consultation in 2023 on creating a smoke-free generation and restricting disposable vape sales were generated by AI bots, finds an analysis of publicly available data and Freedom of Information requests, published online in the journal Tobacco Control.

 

These responses were overwhelmingly targeted at opposing restrictions on disposable vape sales, the scale and directional consistency of which suggest a coordinated campaign, say the researchers.

 

AI bots have been used to spread health misinformation on social media platforms, point out the researchers. But while public consultations are increasingly used to inform health regulation, they are susceptible to automated interference, they add.

 

The researchers therefore wanted to find out if the 2023 public consultation on government proposals to create a smoke-free generation and curb vaping among young people had been subject to automated interference.

 

They drew on published consultation reports and Freedom of Information requests to the Department of Health and Social Care.

 

In all, 118,756 responses were submitted to the consultation, three quarters of which (90,835, 76%), the Department of Health and Social Care identified as fraudulent using bot detection methods.

 

All the bot-generated responses targeted a single multiple choice question opposing proposed restrictions on disposable vape sales. The same number reported learning of the consultation via social media.

 

But after the bot responses were excluded, 77% of the valid respondents supported restrictions on disposable vape sales—the opposite of what the unfiltered dataset would have indicated.

 

“This appears to be the first documented instance of large-scale automated interference in a formal public health policy consultation,” write the researchers.

 

“While it is not possible to ascertain the commercial origins of such a campaign, transnational tobacco companies have sought to swamp earlier public consultations with favourable responses, using mass recruitment campaigns and postcard submissions,” they explain.

 

“The scale and directional consistency of bot responses [in this instance] suggest a coordinated campaign, consistent with prior evidence of tobacco industry efforts to manipulate public consultations through mass coordinated submissions,” they add.

 

The UK’s Tobacco and Vapes Act received Royal Assent on 29 April 2026, making it illegal to ever sell tobacco products to anyone born on or after 1 January 2009, and restricting the supply and sale of disposable vapes.

 

The researchers acknowledge several limitations to their findings. For example, they couldn’t independently verify the bot detection methods used by the Department of Health and Social Care as this information isn’t publicly available, and the metadata and demographic information on the respondents was deemed exempt under Freedom of Information legislation.

 

The findings may not be applicable to other policy topics either, and on the basis of the information received, it’s impossible to attribute source, intent, or commercial sponsorship,  emphasise the researchers.

 

But they conclude: “As bot sophistication increases and public consultations expand across regulatory contexts, strengthening detection capacity and governance safeguards will be essential to maintaining the integrity of public health policymaking, particularly in lower-resource settings where screening infrastructure may be absent.”

Tuesday, October 27, 2026

VAPE CONTRADICTION

E-cigarettes help smokers quit even without specialist support





Queen Mary University of London






A new study by Queen Mary University of London, funded by the National Institute for Health and Care Research (NIHR), has found that e-cigarettes can help people quit smoking even without ongoing behavioural support.

The randomised controlled trial, published in NEJM Evidence and involving 1,170 adults given e-cigarettes, found that 11.3 per cent of participants given e-cigarettes alone successfully quit smoking for six months, compared with 6.4 per cent of those who received automated NHS stop-smoking messages – making them 76 per cent more likely to quit.

Adding telephone-based behavioural support nearly doubled quit rates. Among participants receiving e-cigarettes alongside counselling, 21.1 per cent successfully stopped smoking for six months, compared with 11.3 per cent receiving e-cigarettes alone.

Previous research has established that e-cigarettes can help smokers quit, but most clinical trials have provided them alongside ongoing behavioural support. This study addresses an important unanswered question: whether e-cigarettes remain effective when specialist counselling is unavailable or unwanted, and how much additional benefit counselling provides.

Participants were randomly assigned to receive automated NHS stop-smoking emails, an e-cigarette starter pack alone, or an e-cigarette starter pack alongside telephone counselling. Those receiving additional support were offered five telephone sessions over four weeks. Quitting was verified using carbon monoxide breath tests.

The researchers also found that more than two-thirds of participants who successfully quit in the NHS supportive messages group were using e-cigarettes at six months. When participants who used treatments outside their allocated group were excluded, the quit rate in the supportive messages group fell to 2.7 per cent.

Dr Katie Myers- Smith, lead author and Senior Lecturer in Health Psychology at Queen Mary said: “One of the most important findings is that smokers don’t necessarily need specialist counselling to benefit from e-cigarettes, but when counselling is available, it can make a difference. In our trial, adding telephone support almost doubled the proportion of people who successfully quit.

“This suggests we shouldn’t make counselling a condition of receiving help to stop smoking, but we should make it easy as possible for people to access that extra support.”

The benefits were also evident at 12 months, with sustained quit rates of 16.8 per cent among those receiving e-cigarettes and counselling, nine per cent among those receiving e-cigarettes alone, and 5.4 per cent among those receiving supportive messages.

Most participants who successfully quit smoking with e-cigarettes were still vaping a year later. Vaping is not completely risk-free, but it poses only a small fraction of risks of smoking, and it can protect ex-smokers from post-cessation weight gain and mood changes, and from relapse back to smoking.

The findings strongly support Swap and Stop, a government initiative which provide free vaping starter packs to help smokers quit. The initiative encourages smokers to enlist with the UK stop-smoking services for behavioural support but does not make it mandatory.  E-cigarettes help smokers quit even without ongoing counselling, but behavioural support increases their efficacy further.

Hayden McRobbie, a collaborator on the study and Professor of Population Health at Queen Mary and said: “These findings matter for stop-smoking services. Not everyone who wants to quit smoking is able or willing to attend regular counselling sessions, and our results show that they can still benefit from simply being offered an e-cigarette.

“At the same time, the extra benefit we saw from telephone support still matters. Stop smoking services are still needed to make both effective quitting aids and the additional support available as widely as possible.”

Peter Hajek, senior author and Professor of Clinical Psychology at Queen Mary said: “This trial adds to the strong evidence that e-cigarettes help people stop smoking, and clinicians can recommend them with confidence. Clinicians should also take the opportunity to explain that vaping is far less harmful than smoking, and that ex-smokers can keep using an e-cigarette for as long as they need to feel sure they won’t go back to smoking.”

ENDS

Thursday, October 08, 2026

  

Chronic respiratory disease burden rises in the WHO Western Pacific Region despite falling age-standardized mortality



A GBD 2023 analysis in Med Research highlights aging, COPD, tobacco smoking and air pollution as central priorities




International Society for Health Data Science

Trends in age-standardized rates of chronic respiratory diseases in the Western Pacific Region, 1990-2023

image: 

Time trends are shown in separate panels for (A) age‐standardized incidence rate (ASIR), (B) age‐standardized prevalence rate (ASPR), (C) age‐standardized mortality rate (ASMR), and (D) age‐standardized DALY rate (ASDR). Solid lines represent point estimates, and shaded regions indicate 95% uncertainty intervals. EAPC values with 95% confidence intervals are shown within each panel. All rates are expressed per 100,000 population.

view more 

Credit: Zhang Yue | Yi‐Cheng Fu | Wen Zuo | Li‐Na Wang| Xing‐Xing Suo | Peng Sun | Jin‐Hui Bian| Ming‐Yan Wang

A new analysis in Med Research uses the Global Burden of Disease 2023 study to assess chronic respiratory diseases (CRDs) across 37 countries and territories in the WHO Western Pacific Region from 1990 to 2023. The study examined incidence, prevalence, deaths, disability-adjusted life years (DALYs), age-standardized rates, disease subtypes and selected modifiable risk factors.

By 2023, CRDs accounted for 22.0 million incident cases, 155.9 million prevalent cases, 1.4 million deaths and 29.9 million DALYs in the region. Compared with 1990, absolute numbers increased across all major indicators, largely reflecting population growth and aging. At the same time, age-standardized mortality and DALY rates declined substantially, with estimated annual percentage changes of -2.67% and -2.31%, respectively.

The burden was concentrated among older adults and remained higher in males. COPD dominated the disease composition, accounting for 75.3% of CRD-related DALYs in 2023. Among the selected risk factors, tobacco smoking and air pollution were the leading modifiable contributors, followed by occupational exposure.

Illustrative comparisons of China, Japan, the Republic of Korea, Vietnam, the Philippines and Australia showed marked heterogeneity within the region. The findings suggest that respiratory-health strategies in the Western Pacific Region should combine sustained tobacco control, cleaner air, stronger occupational protection, earlier detection and long-term management of chronic respiratory conditions.

Because the analysis relies on GBD modelled estimates, country-level differences in diagnostic access, data completeness and cause-of-death coding should be considered when interpreting cross-country comparisons.

Even brief e-cigarette use can cause lasting lung damage and weaken defenses against respiratory viruses, study finds




National Jewish Health






Just days of e-cigarette vapor exposure can injure the lungs' most delicate tissue and leave it more vulnerable to viral infection, according to a study led by National Jewish Health researchers and published in JCI Insight.(Opens in a new window)

The research team studied human lung epithelial and endothelial cells, along with precision-cut human lung tissue, all taken from the distal lung — the deep, delicate region where oxygen passes into the bloodstream. They exposed these tissues to e-cigarette vapor alone, and separately tested vapor exposure followed by infection with a respiratory virus, in preclinical models. Within 24 hours, e-cigarette vapor damaged the protective barrier of the distal lung, triggered cellular stress, impaired cells’ internal process for clearing damaged components, slowed cell growth and repair, and increased cell death.

Strikingly, signs of lung stress persisted 10 days after just a five-day exposure period ended. The team observed lasting changes in barrier function, tissue remodeling, and Th1 immunity — a branch of the immune system critical to fighting viral infections.

Prior vaping exposure also increased SARS-CoV-2 viral burden and suppressed several antiviral genes following infection.

“Our findings suggest that even short-term vaping exposure can initiate injury in the deepest and most delicate regions of the lung,” said senior author Irina Petrache, MD, pulmonologist and chief of the Division of Pulmonary, Critical Care and Sleep Medicine at National Jewish Health. “Importantly, some effects persisted after exposure ended and altered the immune response to a subsequent viral infection.”

The findings, which will need to be confirmed in future studies in people, point to biological mechanisms that may help explain why vaping has been linked to lung injury and greater susceptibility to respiratory infections. The researchers noted that repeated exposure could potentially contribute to chronic lung disease by sustaining cellular injury and disrupting normal repair.
 

National Jewish Health is the leading respiratory hospital in the nation delivering excellence in multispecialty care and world class research. Founded in 1899 as a nonprofit hospital, National Jewish Health today is the only facility in the world dedicated exclusively to groundbreaking medical research and treatment of children and adults with respiratory, cardiac, immune and related disorders. Patients and families come to National Jewish Health from around the world to receive cutting-edge, comprehensive, coordinated care. To learn more, visit njhealth.org or the media resources page.

Monday, September 28, 2026

One in nine older adults who use cannabis meet criteria for cannabis use disorder


University of California - San DiegoFacebook





Cannabis use is becoming increasingly common among older adults in the United States, but less is known about how often cannabis use may become problematic in this population. A new study from University of California San Diego School of Medicine finds that among the estimated 8.9% of adults age 65 and older who used cannabis in the past year, more than one in nine (11.4%) met the criteria for cannabis use disorder (CUD), a pattern of cannabis use that causes problems or interferes with daily life. The study was published on Sept. 28, 2026, in the journal Addiction.

Older adults may be at greater risk for some harms associated with cannabis use because of age-related changes in the body, as well as the higher prevalence of chronic diseases and use of prescription medications in this population. Previous studies have linked cannabis use among older adults to increased risk for chronic diseases, cognitive impairment, falls, cannabis poisoning and cannabis-related emergency health care visits. However, less research has examined cannabis use disorder among older adults.

“While there is a lot of attention on how cannabis may help common chronic symptoms older adults experience or the possible acute adverse effects in this population, less focus has been on cannabis use disorder,” said Benjamin Han, MD, assistant professor at UC San Diego School of Medicine and lead author of the study. “It is important to recognize that any psychoactive substance, including cannabis, can lead to a harmful pattern of use, including among older adults.”

The researchers analyzed data from the 2021–2024 National Survey on Drug Use and Health, a nationally representative survey of U.S. residents. The analysis included 21,189 adults aged 65 and older. Among older adults who reported using cannabis in the past 12 months, 11.4% met criteria for CUD — spending time obtaining, using and recovering from the drug’s effects (74.4%) and craving (67.5%). Of those, 76% had mild CUD, 20.1% had moderate CUD and 3.9% had severe CUD.

Smoking was the most common way older adults used cannabis, reported by 65.8% of those who used cannabis in the past year, followed by eating or drinking cannabis products (40.5%) and vaping (15.4%). About one in five (19.9%) older adults who used cannabis in the past year said a doctor had recommended some or all of their cannabis use.

The likelihood of CUD was greater among older adults who used cannabis more frequently. Those who used cannabis for at least 300 days in the past year were almost four times more likely to meet criteria for CUD than those who used it less frequently. Smoking cannabis was also strongly associated with CUD in this population. CUD was also more common among older adults with past-year mental illness, tobacco use and use of drugs other than cannabis.

Among older adults who met Diagnostic and Statistical Manual of Mental Health Disorders (DSM)-5 criteria for CUD, the most commonly reported activity included spending a great deal of time obtaining or using cannabis (74.4%), craving (67.5%) and tolerance (48.3%). The researchers note that most cases were mild, suggesting an opportunity for early intervention, while nearly a quarter were moderate or severe.

The findings highlight the importance of screening older adults for unhealthy cannabis use and discussing cannabis use as part of routine health care, particularly as cannabis becomes more widely available and is increasingly used for medical and other health-related reasons.

Read the full study: “Cannabis Use and Cannabis Use Disorder among Older Adults in the United States”

Additional co-authors on the study include: Evan Eschliman from Duke University. Joseph Palamar from New York University. Mireia Triguero Roura and Pia Mauro from Rutgers Health.

The research was supported by multiple grants from the National Institute on Drug Abuse and the UC San Diego Sam and Rose Stein Institute for Research on Aging.

Authors declare no competing interests.

Tuesday, September 08, 2026

 

Second-hand smoke: 2.7 billion exposed, 767 million of them children, study finds

A third of the world’s population exposed to second-hand smoke.
Copyright Cleared/Canva


By Marta Iraola Iribarren
Published on

Second-hand smoke causes serious health harm, including heart disease, respiratory illness and cancer, and remains a leading cause of preventable death worldwide.

A third of the world’s population is exposed each year to second-hand smoke — also known as passive smoking — which continues to be a major source of illness and mortality among non-smokers.

An estimated 2.71 billion people around the world were exposed to second-hand smoke— a combination of two types of smoke inhaled by non-smokers — in 2023, contributing to 1.66 million deaths. This includes 767 million children under 15, who are especially vulnerable, along with 1.49 billion women.

These new findings come from the Global Burden of Disease (GBD) 2023 study, published in The Lancet Public Health, which estimated second-hand smoke exposure and health impacts across 204 countries and territories between 1990 and 2023.

Need for stronger regulation

Despite the scale of exposure, the study found that approximately 70% of the world’s population is not protected by comprehensive smoke-free laws.

As of 2024, only 79 countries, approximately 70% of them in the Americas, have achieved the highest protection standards of the World Health Organization framework — with all public places completely smoke-free or at least 90% of the population covered by legislation.

The proportion of the global population covered by comprehensive smoke-free legislation has increased from 3% in 2007 to 33% in 2024, now covering 2.6 billion people.

However, the authors noted that while smoke-free policies directly reduce smoke exposure, there is a need for extra measures such as tobacco taxation, marketing bans, plain packaging and cessation programmes.

Regional patterns

The researchers found that the number of people impacted by second-hand smoke exposure remained broadly the same globally, but rose sharply in sub-Saharan Africa, North Africa and the Middle East, which they attributed to population growth.

The exposure prevalence in the Central Europe, Eastern Europe and Central Asia region was 37.7% — higher than the global average of 33.9% — affecting 146 million people.

Most of the countries in Western Europe were included in the “high-income super region,” which showed some of the most significant progress in reducing passive smoking.

Denmark and Norway achieved some of the world's largest reductions since 1990, at -48,8% and -44,3%, respectively.

Broad health impacts

Beyond how many people are exposed, the report found that second-hand smoke accounted for the loss of 44.8 million years of healthy life and continues to be a major contributor to disability and premature death.

While a smoker inhales "mainstream smoke" through the cigarette's filter, non-smokers primarily breathe in sidestream smoke. This is unfiltered and contains higher per-unit concentrations of toxic and carcinogenic compounds than the smoke inhaled by the smoker.

The researchers estimated that second-hand smoke remains a substantial driver of global health loss, particularly through cardiovascular and paediatric respiratory diseases.

Exposure to tobacco smoke was associated with several health conditions, including stroke, lower respiratory infections, chronic obstructive pulmonary disease, asthma, type 2 diabetes and cancers of the trachea, lung and breast.